Endotronix | iBIO

Breakthrough in Heart Failure Management: Endotronix’s Cordella System Receives FDA Approval

by John Conrad | Jun 25, 2024 | NewsBrief

In a significant advancement for heart failure treatment, Endotronix, Inc. has announced FDA Premarket Approval for their Cordella™ Pulmonary Artery (PA) Sensor System. This innovative technology promises to revolutionize the way we manage heart failure patients,...

Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial

by John Conrad | Feb 18, 2020 | Member News

Study to support U.S. FDA approval of the Cordella™ Pulmonary Artery Pressure Sensor System for the treatment of patients with chronic heart failure Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart...

Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System

by John Conrad | Nov 18, 2019 | Member News

Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), presented positive first-in-human data of the Cordella™ Pulmonary Artery (PA) Pressure Sensor System (Cordella Sensor). Data was presented...